Huons Co., Ltd. logo

Huons Co., Ltd. (243070)

Market Open
11 Aug, 06:30
KRX SM KRX SM
26,700. 00
+300
+1.1364%
329.74B Market Cap
- P/E Ratio
2,280% Div Yield
3,944 Volume
- Eps
26,400
Previous Close
Add Transaction
Day Range
26,300 26,850
Year Range
22,500 41,500
Want to track 243070 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

243070 trading today higher at ₩26,700, an increase of 1.1364% from yesterday's close, completing a monthly decrease of -1.8382% or -₩500. Over the past 12 months, 243070 stock lost -3.2609%.
243070 pays dividends to its shareholders, with the most recent payment made on Jun 15, 2026. The next estimated payment will be in In 1 month on Sep 15, 2026 for a total of ₩200.
Huons Co., Ltd. has completed 7 stock splits, with the recent split occurring on Dec 29, 2021.
The company's stock is traded on one exchange.

243070 Chart

People also search for

Hyundai Motor Co.
403,500
-1.1029%
Hyundai Motor Co. Ltd.
192,400
-0.4141%
Hyundai Motor Co. Ltd. Preferred
198,200
+0.3544%
Hyundai Motor Co., Ltd. Preferred
200,000
-0.7444%
Kia Corporation
135,400
-0.0738%

Huons Co., Ltd. (243070) FAQ

What is the stock price today?

The current price is ₩26,700.00.

On which exchange is it traded?

Huons Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 243070.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2,280%.

What is its market cap?

As of today, the market cap is 329.74B.

Has Huons Co., Ltd. ever had a stock split?

Huons Co., Ltd. had 7 splits and the recent split was on Dec 29, 2021.

Huons Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
- CEO
KRX SM Exchange
KR7243070000 ISIN
South Korea Country
- Employees
26 May 2026 Last Dividend
27 Dec 2019 Last Split
- IPO Date

Overview

Huons Co., Ltd., initially known as Kwang Myung Pharm before its name change in June 2003, stands as a significant provider of medical solutions aimed at improving human health both within Korea and internationally. With its foundation laid in 1965, the company has its headquarters nestled in Seongnam, South Korea, symbolizing over five decades of dedicated service in the pharmaceutical industry. Huons Co., Ltd. is recognized for its extensive contribution to the medical field, marked by its diverse range of products catering to various health conditions and medical requirements.

Products and Services

  • Oral Solid Form Drugs:

    These include a wide assortment of drugs tailored for various health conditions such as circulatory and metabolic issues, antipyretic (fever-reducing), analgesic (pain-relieving), anti-inflammatory, and musculoskeletal system disorders. Additional categories encompass digestive and respiratory system medications, antihistamines, antibiotics, well-being supplements, urogenital system drugs, and other chemotherapeutic agents targeted at treating a plethora of conditions.

  • Injection Products:

    Huons Co., Ltd. offers a comprehensive line of injectable products, which comprises anesthetics, antipyretic, analgesic and anti-inflammatory drugs, skeletal muscle relaxants, antispasmodics, antihistamines, products for the circulatory and respiratory systems, adrenocortical hormones, enzymes, minerals, solvents, calcium supplements, hemostatics, antidotes, antibiotics, metabolic aids, hyaluronic acid for joint health, well-being injections, anticoagulants, and other tissue cell system treatments, encapsulating a broad spectrum of medical needs.

  • Eye Drops and Bio Products:

    The company also extends its expertise to the production of eye drops, catering to various ophthalmic conditions, alongside bio products that leverage biotechnological advancements for healthcare improvements.

  • Medical Devices:

    Aside from pharmaceuticals, Huons Co., Ltd. diversifies its product offerings by including medical devices in its catalog. These devices are designed to aid in the diagnosis, treatment, and monitoring of various medical conditions, thereby complementing the company's drug therapies.

Contact Information

Address: #253C-902 Pangyo-ro
Phone: 82 2 854 4700